An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistanceThijs J. Hagenbeek, Anwesha Dey|Nature Cancer|2023Cited by 188
R-Roscovitine simultaneously targets both the p53 and NF-κB pathways and causes potentiation of apoptosis: implications in cancer therapyAnwesha Dey, David P. Lane|Cell Death and Differentiation|2007Cited by 73
Targeting the Hippo pathway in cancers via ubiquitination dependent TEAD degradationTrang H. Pham, Anwesha Dey|eLife|2024Cited by 1